146 related articles for article (PubMed ID: 18467710)
1. Karyotype evolution on fluorescent in situ hybridization analysis is associated with short survival in patients with chronic lymphocytic leukemia and is related to CD49d expression.
Shanafelt TD; Hanson C; Dewald GW; Witzig TE; LaPlant B; Abrahamzon J; Jelinek DF; Kay NE
J Clin Oncol; 2008 May; 26(14):e5-6. PubMed ID: 18467710
[No Abstract] [Full Text] [Related]
2. Relevance of CD49d protein expression as overall survival and progressive disease prognosticator in chronic lymphocytic leukemia.
Gattei V; Bulian P; Del Principe MI; Zucchetto A; Maurillo L; Buccisano F; Bomben R; Dal-Bo M; Luciano F; Rossi FM; Degan M; Amadori S; Del Poeta G
Blood; 2008 Jan; 111(2):865-73. PubMed ID: 17959854
[TBL] [Abstract][Full Text] [Related]
3. CD49d expression is an independent predictor of overall survival in patients with chronic lymphocytic leukaemia: a prognostic parameter with therapeutic potential.
Shanafelt TD; Geyer SM; Bone ND; Tschumper RC; Witzig TE; Nowakowski GS; Zent CS; Call TG; Laplant B; Dewald GW; Jelinek DF; Kay NE
Br J Haematol; 2008 Mar; 140(5):537-46. PubMed ID: 18275431
[TBL] [Abstract][Full Text] [Related]
4. [The correlation of CD49d expression pattern with molecular genetics and hotspot gene mutants in patients with chronic lymphocytic leukemia].
Zhu J; Liu L; Chen X; Liu F; Zhao SS; Jin HM; Qiu HR; Qiao C; Li JY; Wu YJ
Zhonghua Xue Ye Xue Za Zhi; 2022 Jun; 43(6):463-468. PubMed ID: 35968588
[No Abstract] [Full Text] [Related]
5. CD49d is the strongest flow cytometry-based predictor of overall survival in chronic lymphocytic leukemia.
Bulian P; Shanafelt TD; Fegan C; Zucchetto A; Cro L; Nückel H; Baldini L; Kurtova AV; Ferrajoli A; Burger JA; Gaidano G; Del Poeta G; Pepper C; Rossi D; Gattei V
J Clin Oncol; 2014 Mar; 32(9):897-904. PubMed ID: 24516016
[TBL] [Abstract][Full Text] [Related]
6. Low CD49d expression and long telomere identify a chronic lymphocytic leukemia subset with highly favourable outcome.
Rossi D; Bodoni CL; Zucchetto A; Rasi S; De Paoli L; Fangazio M; Rossi FM; Ladetto M; Gattei V; Gaidano G
Am J Hematol; 2010 Aug; 85(8):619-22. PubMed ID: 20578200
[No Abstract] [Full Text] [Related]
7. CD49d shows superior performance characteristics for flow cytometric prognostic testing in chronic lymphocytic leukemia/small lymphocytic lymphoma.
Gooden CE; Jones P; Bates R; Shallenberger WM; Surti U; Swerdlow SH; Roth CG
Cytometry B Clin Cytom; 2018 Jan; 94(1):129-135. PubMed ID: 27221715
[TBL] [Abstract][Full Text] [Related]
8. High CD49d protein and mRNA expression predicts poor outcome in chronic lymphocytic leukemia.
Nückel H; Switala M; Collins CH; Sellmann L; Grosse-Wilde H; Dührsen U; Rebmann V
Clin Immunol; 2009 Jun; 131(3):472-80. PubMed ID: 19318232
[TBL] [Abstract][Full Text] [Related]
9. Prognostic and predictive factors in patients with chronic lymphocytic leukemia: relevant in the era of novel treatment approaches?
Mertens D; Stilgenbauer S
J Clin Oncol; 2014 Mar; 32(9):869-72. PubMed ID: 24516034
[No Abstract] [Full Text] [Related]
10. CD49d and CD26 are independent prognostic markers for disease progression in patients with chronic lymphocytic leukemia.
Ibrahem L; Elderiny WE; Elhelw L; Ismail M
Blood Cells Mol Dis; 2015 Aug; 55(2):154-60. PubMed ID: 26142332
[TBL] [Abstract][Full Text] [Related]
11. Overexpression of CD49d in trisomy 12 chronic lymphocytic leukemia patients is mediated by IRF4 through induction of IKAROS.
Fiorcari S; Benatti S; Zucchetto A; Zucchini P; Gattei V; Luppi M; Marasca R; Maffei R
Leukemia; 2019 May; 33(5):1278-1302. PubMed ID: 30659236
[No Abstract] [Full Text] [Related]
12. In contrast to high CD49d, low CXCR4 expression indicates the dependency of chronic lymphocytic leukemia (CLL) cells on the microenvironment.
Kriston C; Plander M; Márk Á; Sebestyén A; Bugyik E; Matolcsy A; Barna G
Ann Hematol; 2018 Nov; 97(11):2145-2152. PubMed ID: 29955944
[TBL] [Abstract][Full Text] [Related]
13. CD49d (ITGA4) expression is a predictor of time to first treatment in patients with chronic lymphocytic leukaemia and mutated IGHV status.
Baumann T; Delgado J; Santacruz R; Martínez-Trillos A; Rozman M; Aymerich M; López C; Costa D; Carrió A; Villamor N; Montserrat E
Br J Haematol; 2016 Jan; 172(1):48-55. PubMed ID: 26559905
[TBL] [Abstract][Full Text] [Related]
14. CD49d in B-cell chronic lymphocytic leukemia: correlated expression with CD38 and prognostic relevance.
Zucchetto A; Bomben R; Dal Bo M; Bulian P; Benedetti D; Nanni P; Del Poeta G; Degan M; Gattei V
Leukemia; 2006 Mar; 20(3):523-5; author reply 528-9. PubMed ID: 16408095
[No Abstract] [Full Text] [Related]
15. The CD49d/CD29 complex is physically and functionally associated with CD38 in B-cell chronic lymphocytic leukemia cells.
Zucchetto A; Vaisitti T; Benedetti D; Tissino E; Bertagnolo V; Rossi D; Bomben R; Dal Bo M; Del Principe MI; Gorgone A; Pozzato G; Gaidano G; Del Poeta G; Malavasi F; Deaglio S; Gattei V
Leukemia; 2012 Jun; 26(6):1301-12. PubMed ID: 22289918
[TBL] [Abstract][Full Text] [Related]
16. CD49d is overexpressed by trisomy 12 chronic lymphocytic leukemia cells: evidence for a methylation-dependent regulation mechanism.
Zucchetto A; Caldana C; Benedetti D; Tissino E; Rossi FM; Hutterer E; Pozzo F; Bomben R; Dal Bo M; D'Arena G; Zaja F; Pozzato G; Di Raimondo F; Hartmann TN; Rossi D; Gaidano G; Del Poeta G; Gattei V
Blood; 2013 Nov; 122(19):3317-21. PubMed ID: 24068493
[TBL] [Abstract][Full Text] [Related]
17. NOTCH1 mutations are associated with high CD49d expression in chronic lymphocytic leukemia: link between the NOTCH1 and the NF-κB pathways.
Benedetti D; Tissino E; Pozzo F; Bittolo T; Caldana C; Perini C; Martorelli D; Bravin V; D'Agaro T; Rossi FM; Bomben R; Santinelli E; Zaja F; Pozzato G; Chiarenza A; Di Raimondo F; Del Poeta G; Rossi D; Gaidano G; Dal Bo M; Gattei V; Zucchetto A
Leukemia; 2018 Mar; 32(3):654-662. PubMed ID: 28935990
[TBL] [Abstract][Full Text] [Related]
18. Functional and Clinical Significance of the Integrin Alpha Chain CD49d Expression in Chronic Lymphocytic Leukemia.
Dal Bo M; Tissino E; Benedetti D; Caldana C; Bomben R; Poeta GD; Gaidano G; Rossi FM; Bulian P; Zucchetto A; Gattei V
Curr Cancer Drug Targets; 2016; 16(8):659-668. PubMed ID: 27514846
[TBL] [Abstract][Full Text] [Related]
19. Chromosome aberrations detected by conventional karyotyping using novel mitogens in chronic lymphocytic leukemia with "normal" FISH: correlations with clinicobiologic parameters.
Rigolin GM; Cibien F; Martinelli S; Formigaro L; Rizzotto L; Tammiso E; Saccenti E; Bardi A; Cavazzini F; Ciccone M; Nichele I; Pizzolo G; Zaja F; Fanin R; Galieni P; Dalsass A; Mestichelli F; Testa N; Negrini M; Cuneo A
Blood; 2012 Mar; 119(10):2310-3. PubMed ID: 22246039
[TBL] [Abstract][Full Text] [Related]
20. CD49d expression is an independent risk factor of progressive disease in early stage chronic lymphocytic leukemia.
Rossi D; Zucchetto A; Rossi FM; Capello D; Cerri M; Deambrogi C; Cresta S; Rasi S; De Paoli L; Bodoni CL; Bulian P; Del Poeta G; Ladetto M; Gattei V; Gaidano G
Haematologica; 2008 Oct; 93(10):1575-9. PubMed ID: 18641015
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
